1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

Danlos, F.-X.; Baldini, C.; Texier, M.; Varga, A.; Mouraud, S.; Job, B.; Letourneur, D.; Cassard, L.; Bredel, D.; Laghouati, S.; Adam, J.; Droin, N.; Parpaleix, A.; Chaput-Gras, N.; Rabeau, A.; Massard, C.; Soria, J.-C.; Zalcman, G.; Planchard, D.; Marabelle, A.

Published in

Elsevier, Annals of Oncology, (33), p. S1302-S1303, 2022

DOI: 10.1016/j.annonc.2022.07.1741

Tools

Export citation

Search in Google Scholar

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

Journal article published in 2022 by F.-X. Danlos, C. Baldini, M. Texier, A. Varga, S. Mouraud, B. Job, D. Letourneur, L. Cassard, D. Bredel, S. Laghouati, J. Adam, N. Droin, A. Parpaleix, N. Chaput-Gras, A. Rabeau and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma